Trials / Unknown
UnknownNCT03364920
Serum Maresin-1 Predicts the Severity of Severe Acute Pancreatitis
Serum Maresin-1 Level Predicts the Disease Severity and Clinical Outcomes of Severe Acute Pancreatitis Patients
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Weiqin Li · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
This is a retrospective study about serum Maresin-1 level in different severe acute pancreatitis patients. The investigators want to study the correlation between the level of serum Maresin-1 and the severity of SAP, of course the clinical outcomes. The investigators want to find some biomarkers and strategy target drugs of severe acute pancreatitis.
Conditions
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2019-01-01
- Completion
- 2020-01-01
- First posted
- 2017-12-07
- Last updated
- 2017-12-07
Source: ClinicalTrials.gov record NCT03364920. Inclusion in this directory is not an endorsement.